Current Drug Delivery

Journal Impact Factor: 3.1
Scopus Cite Score: 6.9

Indexed in: Scopus, SCI Expanded, MEDLINE/PubMed

View All
Aims and Scope:
Current Drug Delivery aims to publish peer-reviewed articles, research articles, in-depth reviews/mini-reviews, and drug clinical trials studies in the rapidly developing field of drug delivery. Modern drug research aims to build delivery properties of a drug at the design phase, however in many cases this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves.

The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical and chemical methods. The drugs include a wide range of bioactive compounds from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides and sugars. The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug resistance.

The journal is essential for all pharmaceutical scientists involved in drug design, development and delivery.
Read more...
Start Submission Button Icon

Editor-in-Chief:

  • Min WuWenzhou Institute
    University of Chinese Academy of Sciences
    Beijing
    China

ISSN: 1875-5704

Special Issues With Active Call for Papers

Submission closes on: Jan 18, 2027
Phosphine Compounds in Modern Medicine: Emerging Roles and Therapeutic Potential

Phosphine compounds have emerged as versatile agents in medicinal chemistry, offering unique structural and electronic properties that enable diverse biological applications. This thematic issue explores the expanding role of phosphines in drug design, therapeutic delivery, and bioinorganic mechanisms. From their use as ligands in metal-based drugs to their potential in anticancer, antimicrobial, and antioxidant therapies, phosphine derivatives are gaining attention for their tunable reactivity and biocompatibility. Recent advances in synthetic strategies and mechanistic understanding have... see more

Impact Factor: 3.1
Guest Editor(s): Dr. Urszula Komarnicka
Co-Guest Editor(s): Prof. Edgar Hernan Del Carpio Garcia,Prof. Alessandro Niorettini
Start Submission
Submission closes on: Oct 26, 2026
Innovative Nanocarrier Systems for Tumor Targeting and Therapy

In the rapidly evolving field of nanomedicine, innovative nanocarrier systems have emerged as a transformative approach for enhancing tumor targeting and therapeutic efficacy. These advanced systems leverage smart designs—such as stimuli-responsive materials, biomimetic coatings, and multifunctional architectures—to overcome biological barriers, improve tumor accumulation, and minimize off-target toxicity. This Special Issue invites cutting-edge research exploring novel strategies in nanocarrier development. We welcome contributions on, but not limited to, the following themes: 1. Stimuli-Responsive Nanocarriers Light-, pH-,... see more

Impact Factor: 3.1
Guest Editor(s): Dr. Yonghui Liu
Co-Guest Editor(s): Dr. Qingxiang Guo
Start Submission
Submission closes on: Sep 21, 2026
Nanotherapeutics for Alzheimer’s Disease (AD): Tailored Delivery, Neuroprotection, and Disease Abatement

Alzheimer’s Disease (AD) is one of the highly prevalent, most complex, and destructive neurodegenerative disorders. Complete cure of the disease is still illusive and treatment still involves symptomatic therapeutic interventions. The critical challenges, like penetration of the blood-brain barrier (BBB), targeted delivery of active molecules and scaffolds, and off-target toxicity, are still unmet. Nanotechnology in general and in nanomedicine in particular has offered a transformative path enabling the precision or targeted delivery via tailored nanoparticles.... see more

Impact Factor: 3.1
Guest Editor(s): Dr. Dar Junaid Bashir
Co-Guest Editor(s): Dr. Mohd Salman Saifi
Start Submission